Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for KYMERA THERAPEUTICS INC COMMON STOCK (KYMR).
- Disclosed ownership: 7.1%.
- Date of event: 30 Sep 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 30 Sep 2025 SCHEDULE 13G/A Report for KYMERA THERAPEUTICS INC COMMON STOCK (KYMR)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- KYMERA THERAPEUTICS INC COMMON STOCK
- Symbol
- KYMR
- Shares outstanding
- 71,798,648 shares
- Disclosed Ownership
- 5,097,704 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 12:19:23 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 7.1% ownership in KYMERA THERAPEUTICS INC COMMON STOCK (KYMR) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 12:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 7.1% | 5,097,704 | 4,973,066 | 0 | Ellen York | Vice President |